Neutrexin

Active Ingredient(s): Trimetrexate
FDA Approved: * December 17, 1993
Pharm Company: * MEDIMMUNE ONCOLOGY
Category: Immune System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Neutrexin Overview

Trimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.[1] Uses It has been used with leucovorin in treating pneumocystis pneumonia.[2] It has been investigated for use in treating leiomyosarcoma.[3] It is a methotrexate (MTX) analog that is active against transport-deficient MTX-resistant tumor cells that overcome the acquired and natural resistance to methotrexate. Other uses include skin lymphoma. [4&a...

Read more Neutrexin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Trimetrexate

Recent Neutrexin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Trimetrexate
  • Injection: 200mg, 200mg/vial, 25mg, 25mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Trimetrexate or a similar ingredient: (1 result)